Economic aspect of novel therapeutic regime for mastitis management with minimal use of antibiotics
I Ashraf, HU Malik, M Mir, SU Nabi, A Muhee, A Jan, O Shah and H Hamdani
The present study was conducted in VCSS Shuhama & adjacent area during the year 2011-2013. Economic implications of bovine mastitis were worked out from the loss of production during the disease period, cost of medication and veterinary services and cost of extra labour for the management of the animal during illness. The animals were divided into four group with 10 animals each. Group I included animals treated with antibiotics, Group II included animals treated with antibiotics and sodium citrate @40mg/kg b.wt, Group III included animals treated with antibiotics and sodium citrate @80mg/kg b.wt and Group IV included animals treated with sodium citrate @80mg/kg b.wt. The total cost on account of mastitis was calculated to be ₹ 3135.3± 372.7, 2798.84±228.22, 2479.94 ± 210.34 and 725.60±80.96 in group I, group II, group III and group IV respectively. However, the economic losses in group IV were lowest (₹ 725.60±80.96) and those in group I were highest (₹3135.3 ± 372.7). The framework provided in this paper can provide a basis for a future studies on the economics of mastitis and minimizing economic loss from mastitis management by combination of antibiotic and citrate therapy.
I Ashraf, HU Malik, M Mir, SU Nabi, A Muhee, A Jan, O Shah, H Hamdani. Economic aspect of novel therapeutic regime for mastitis management with minimal use of antibiotics. J Entomol Zool Stud 2018;6(1):710-712.